Key Takeaways
- • Private equity-backed urology practices in Tucson, Arizona abruptly closed in December 2025, leaving cancer patients and other vulnerable populations without access to physicians or medical records after six months' notice of the closure.
- • United Urology Group, the private equity-managed operator, characterized the Tucson situation as an "outlier," but the broader scale of such disruptions remains unknown due to the absence of comprehensive public tracking of physician practice closures across the country.
- • A surge in private equity deals over the past decade has placed tens of thousands of U.S. physicians under management by profit-driven entities, creating systemic vulnerability to care gaps when practices wind down or change hands.
- • Healthcare consolidation experts warn of documented risks: Medicare patients have shown a 13% higher mortality risk post-private equity acquisition, with additional concerns including staffing reductions, cost increases for patients, and pressure on physicians to meet financial targets.
- • The closure exemplifies a critical gap in healthcare regulatory oversight—physician practice transactions and closures are not systematically tracked or publicly reported, limiting visibility into the scale and frequency of patient care disruptions.
Summary
When Donald Burke, a 71-year-old cancer patient, arrived at his Tucson urology clinic in March 2026 for a scheduled follow-up appointment following bladder tumor removal surgery, he encountered locked doors and darkened offices. An automated response informed him his doctor was "no longer with us." The practice had ceased operations in December 2025, along with a second Tucson urology group, after both had joined United Urology Group—a private equity-backed company—in 2021.
The closure left Burke without immediate access to his oncology records and treating physician during a critical recovery period. It took approximately two months for the patient to locate his urologist and resume treatment. For other patients across Southern Arizona, the sudden closure created similar disruptions: lost continuity of care, difficulty accessing medical records, and administrative confusion about where to seek ongoing treatment. The experience underscores a broader vulnerability in American healthcare created by private equity's growing involvement in physician practice management.
United Urology Group characterized the Tucson closures as an "outlier situation," attributing the outcome to undefined factors and deflecting responsibility between the company and the medical practices themselves. However, the precise sequence of events and causal factors remain disputed among doctors, patients, and management entities. Critically, whether this represents an isolated incident or symptomatic of systemic problems is impossible to determine: comprehensive data on physician practice closures are not publicly tracked or centrally reported.
The trend underpinning this risk is substantial. Over the past decade, private equity investments in physician practices have surged, placing tens of thousands of U.S. doctors under management by profit-driven entities. Erin Fuse Brown, a professor at Brown University School of Public Health specializing in healthcare consolidation and private equity involvement, cautioned that such closures reflect inherent structural risks: "There are some downsides to relying on private, profit-seeking investors to finance our healthcare system — this kind of thing can happen." Academic research has identified measurable negative outcomes: Medicare patients faced a 13% higher risk of death following private equity takeovers of their medical practices, equivalent to seven additional deaths per 10,000 patients. Physicians at PE-acquired practices frequently report loss of clinical independence and pressure to meet financial targets, sometimes driving unnecessary testing or service restrictions.
The Tucson case exposes a regulatory blind spot. Without mandatory reporting of practice closures or transactions, the healthcare system lacks visibility into the frequency and scale of patient care disruptions. This information asymmetry prevents policymakers, patients, and investors from accurately assessing the true operational and clinical risks embedded in private equity healthcare consolidation.
The closure left Burke without immediate access to his oncology records and treating physician during a critical recovery period. It took approximately two months for the patient to locate his urologist and resume treatment. For other patients across Southern Arizona, the sudden closure created similar disruptions: lost continuity of care, difficulty accessing medical records, and administrative confusion about where to seek ongoing treatment. The experience underscores a broader vulnerability in American healthcare created by private equity's growing involvement in physician practice management.
United Urology Group characterized the Tucson closures as an "outlier situation," attributing the outcome to undefined factors and deflecting responsibility between the company and the medical practices themselves. However, the precise sequence of events and causal factors remain disputed among doctors, patients, and management entities. Critically, whether this represents an isolated incident or symptomatic of systemic problems is impossible to determine: comprehensive data on physician practice closures are not publicly tracked or centrally reported.
The trend underpinning this risk is substantial. Over the past decade, private equity investments in physician practices have surged, placing tens of thousands of U.S. doctors under management by profit-driven entities. Erin Fuse Brown, a professor at Brown University School of Public Health specializing in healthcare consolidation and private equity involvement, cautioned that such closures reflect inherent structural risks: "There are some downsides to relying on private, profit-seeking investors to finance our healthcare system — this kind of thing can happen." Academic research has identified measurable negative outcomes: Medicare patients faced a 13% higher risk of death following private equity takeovers of their medical practices, equivalent to seven additional deaths per 10,000 patients. Physicians at PE-acquired practices frequently report loss of clinical independence and pressure to meet financial targets, sometimes driving unnecessary testing or service restrictions.
The Tucson case exposes a regulatory blind spot. Without mandatory reporting of practice closures or transactions, the healthcare system lacks visibility into the frequency and scale of patient care disruptions. This information asymmetry prevents policymakers, patients, and investors from accurately assessing the true operational and clinical risks embedded in private equity healthcare consolidation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.